Status:
COMPLETED
Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan
Lead Sponsor:
Hospital Universitario Getafe
Conditions:
Thromboangiitis Obliterans
Eligibility:
All Genders
18-65 years
Brief Summary
This study assessed the effectiveness and safety of bosentan when administered to thromboangiitis obliterans (Buerger's disease)patients. A clinical pilot study was designed,included in which patients...
Eligibility Criteria
Inclusion
- Critical ischemia in any extremity, causing pain at rest or non-healing ischemic ulcers, present for at least four weeks with no evidence of improvement in response to conventional treatment.
Exclusion
- Being candidates for surgical or endovascular revascularisation of the extremity studied.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01447550
Start Date
January 1 2009
End Date
January 1 2011
Last Update
August 16 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Getafe
Getafe, Getafe, Spain, 28901
2
Hospital Universitario Getafe
Getafe, Madrid, Spain, 28905